PK
Insider
Peter Kaiser
Chief Development OfficerPeter Kaiser (Chief Development Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ocular Therapeutix, Inc. (OCUL). The largest single filing was $106K of OCUL (9,653 sh × $11.03, as filed), executed Oct 2 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$106K
shares × price, as filed
Last traded
Oct 2 2025
Filed Oct 6 2025
Median ADV $29.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $106K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
OCULRecent filings
OCULSALE
Ocular Therapeutix, Inc.
View filing →
$106K9,653 sh × $11.03
Exec Oct 2 2025
Filed Oct 6 2025 · 5:30 PM ET